MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
companies in this sector in Belgium:
sales of 9.06 million Euro [US$10.59 million]
(55.53 million Euro [US$64.95 million]
of which 100%
was Nanobodies), and
(36.42 million Euro [US$42.59 million]
of which 55%
was Upfront Payments).
MDxHealth S.A. reported sales of 35.56 million Euro (US$41.59 million)
December of 2017.
increase of 31.0%
versus 2016, when the company's sales were 27.15 million Euro.
Sales at MDxHealth S.A. have increased during each of the previous five years
(and since 2012, sales have increased a total of 673%).